Precision Biosciences DTIL
NASDAQ DTIL
$6.25 -0.08 (-1.26%)
As of: Oct 2, 2026 · 1:55 PM EDT

Precision Biosciences (DTIL) Non Operating Interest Expenses (2019 - 2026)

Updated

Precision Biosciences (DTIL) posted Non Operating Interest Expenses of $300,000 for fiscal Q2 2026 (quarter ended Jun 30, 2026), down 16.2% from $358,000 a year earlier and down 3.5% from the prior quarter.

Analysis

Precision Biosciences (DTIL) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Precision Biosciences was $1.32 million, down 2.9% year-over-year; for FY2025 (ended Dec 31, 2025), it came in at $1.42 million, down 20.2% from FY2024.

  • Annual Non Operating Interest Expenses shows a four-year compound annual growth rate of 81.2% (FY2021 to FY2025).
  • In prior fiscal years, Precision Biosciences' Non Operating Interest Expenses was $1.78 million in FY2024 (-20.1%), $2.23 million in FY2023 (+100.7%), $1.11 million in FY2022 (+741.7%) and $132,000 in FY2021.
  • The fiscal Q2 2026 figure stands as the lowest quarterly Non Operating Interest Expenses since fiscal Q3 2024.
  • On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last three quarters, with an average decline of 20.1% over the last eight quarters.
  • The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was fiscal Q4 2022, with growth of 817.0%; the weakest was fiscal Q3 2024, with a decline of 55.6%.
  • According to Business Quant data, Non Operating Interest Expenses for the three prior fiscal quarters was $311,000 (Q1 2026), $348,000 (Q4 2025) and $362,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Precision Biosciences 165.47 Mn -183.71 Mn - 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Mar 31, 2026 311,000.00
Dec 31, 2025 348,000.00
Sep 30, 2025 362,000.00
Jun 30, 2025 358,000.00
Mar 31, 2025 354,000.00
Dec 31, 2024 392,000.00
Sep 30, 2024 256,000.00
Jun 30, 2024 560,000.00
Mar 31, 2024 574,000.00
Dec 31, 2023 579,000.00
Sep 30, 2023 576,000.00
Jun 30, 2023 553,000.00
Mar 31, 2023 522,000.00
Dec 31, 2022 486,000.00
Sep 30, 2022 405,000.00
Jun 30, 2022 178,000.00
Mar 31, 2022 42,000.00
Dec 31, 2021 53,000.00
Sep 30, 2021 55,000.00
API Access

Precision Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=DTIL&period=max&api_key=YOUR_API_KEY